Early atherosclerotic plaques show evidence of infection by Chlamydia pneumoniae

Frontiers in Bioscience - Elite

Volumn 4 E, Issue 7, 2012, Pages 2423-2432

  Luque, Ana ^a,b,c   Turu, Marta M ^b   Rovira, Norma ^a   Juan Babot, Josep Oriol ^b   Slevin, Mark ^c,d   Krupinski, Jerzy ^a,b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b Institut Català de Ciències Cardiovasculars   (Spain)

^c BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^d MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Atherosclerosis; Carotid artery; Chlamydia pneumoniae; Stroke

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; PEROXIDASE; PRIMER DNA;

AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; CAROTID ARTERY OBSTRUCTION; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CHLAMYDIAL PNEUMONIA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; MALE; MIDDLE CEREBRAL ARTERY; POLYMERASE CHAIN REACTION; ATHEROSCLEROSIS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY;

CHLAMYDOPHILA PNEUMONIAE;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; BASE SEQUENCE; CAROTID ARTERIES; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; DNA PRIMERS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; POLYMERASE CHAIN REACTION;

EID: 84867301617     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. A C Nicholson, D P Hajjar: Herpesvirus in atherosclerosis and thrombosis: etiologic agents or ubiquitous bystanders? Arterioscler Thromb Vasc Biol 18, 339-348 (1998)) (Pubitemid 28125627)
2. K N Fish, C Soderberg-Naucler, L K Mills, S Stenglein, J A Nelson: Human cytomegalovirus persistently infects aortic endothelial cells. J Virol 72, 5661-5668 (1998)) (Pubitemid 28283351)
3. S F Ameriso, E A Fridman, R C Leiguarda, G E Sevlever: Detection of Helicobacter pylori in human carotid atherosclerotic plaques. Stroke 32, 385-391 (2001)) (Pubitemid 32155223)
4. S F Ameriso, A Ruiz Villamil, C Zedda, J C Parodi, S Garrido, M I Sarchi, M Schultz, J Boczkowski, G E Sevlever: Heme oxygenase-1 is expressed in carotid atherosclerotic plaques infected by Helicobacter pylori and is more prevalent in asymptomatic subjects. Stroke 36, 1896-1900 (2005)) (Pubitemid 41266522)
5. P Saikku, M Leinonen, L Tenkanen, E Linnanmaki, M R Ekman, V Manninen, M Manttari, M H Frick, J K Huttunen: Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 116, 273-278 (1992))
6. R LaBiche, D Koziol, T C Quinn, C Gaydos, S Azhar, G Ketron, S Sood, T J DeGraba: Presence of Chlamydia pneumoniae in human symptomatic and asymptomatic carotid atherosclerotic plaque. Stroke 32, 855-860 (2001)) (Pubitemid 32285148)
7. K Ouchi, B Fujii, S Kudo, M Shirai, K Yamashita, T Gondo, T Ishihara, H Ito, T Nakazawa: Chlamydia pneumoniae in atherosclerotic and nonatherosclerotic tissue. J Infect Dis 181 (Suppl 3), S441-443 (2000)) (Pubitemid 30416114)
8. G Satpathy, A Bhan, A Sharma, U Kar: Detection of Chlamydophila pneumoniae (Chlamydia pneumoniae) in endarteroctomy specimens of coronary heart diseases patients. Indian J Med Res 128, 658-662 (2008))
9. P Apfalter, F Blasi, J Boman, C Gaydos, M Kundi, M Maass, A Makristathis, A Meijer, R Nadrchal, K Persson, M L Rotter, C Y William Tong, G Stanek, A M Hirschl: Multicenter comparison trial of DNA extraction methods and PCR assays for detection of Chlamydia pneumoniae in endarterectomy specimens. J Clin Microbiol 39, 519-524 (2001)) (Pubitemid 32150811)
10. P Apfalter, W Barousch, M Nehr, B Willinger, M Rotter, A M Hirschl: No evidence of involvement of Chlamydia pneumoniae in severe cerebrovascular atherosclerosis by means of quantitative real-time polymerase chain reaction. Stroke 35, 2024-2028 (2004)) (Pubitemid 39129553)
11. S Hirono, G N Pierce: Dissemination of Chlamydia pneumoniae to the vessel wall in atherosclerosis. Mol Cell Biochem 246, 91-95 (2003)) (Pubitemid 36798727)
12. M Ieven, V Y Hoymans: Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence. J Clin Microbiol 43, 19-24 (2005)) (Pubitemid 40096274)
13. M Cochrane, A Pospischil, P Walker, H Gibbs, P Timms: Discordant detection of Chlamydia pneumoniae in patients with carotid artery disease using polymerase chain reaction, immunofluorescence microscopy and serological methods. Pathology 37, 69-75 (2005)) (Pubitemid 40314452)
14. V Y Hoymans, J M Bosmans, D Ursi, W Martinet, F L Wuyts, E Van Marck, M Altwegg, C Vrints, M Ieven: Immunohistostaining assays for detection of Chlamydia pneumoniae in atherosclerotic arteries indicate crossreactions with nonchlamydial plaque constituents. J Clin Microbiol 42, 3219-3224 (2004)) (Pubitemid 38938083)
15. S F Dowell, R W Peeling, J Boman, G M Carlone, B S Fields, J Guarner, M R Hammerschlag, L A Jackson, C Kuo, M Maass, T O Messmer, D F Talkington, M L Tondella, S R Zaki: Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis 33, 492-503 (2001))
16. P Apfalter, M R Hammerschlag, J Boman: Reliability of nested PCR for the detection of Chlamydia pneumoniae in carotid artery atherosclerosis. Stroke 34, e73-75; author reply e73-75 (2003))
17. T Lajunen, P Vikatmaa, T Ikonen, M Lepantalo, K Lounatmaa, R Sormunen, A Rantala, M Leinonen, P Saikku: Comparison of polymerase chain reaction methods, in situ hybridization, and enzyme immunoassay for detection of Chlamydia pneumoniae in atherosclerotic carotid plaques. Diagn Microbiol Infect Dis 61, 156-164 (2008)) (Pubitemid 351680365)
18. M Krull, A C Klucken, F N Wuppermann, O Fuhrmann, C Magerl, J Seybold, S Hippenstiel, J H Hegemann, C A Jantos, N Suttorp: Signal transduction pathways activated in endothelial cells following infection with Chlamydia pneumoniae. J Immuno 162, 4834-4841 (1999)) (Pubitemid 29314887)
19. R E Molestina, R D Miller, J A Ramirez, J T Summersgill: Infection of human endothelial cells with Chlamydia pneumoniae stimulates transendothelial migration of neutrophils and monocytes. Infect Immun 67, 1323-1330 (1999)) (Pubitemid 29108512)
20. B K Coombes, J B Mahony: Chlamydia pneumoniae infection of human endothelial cells induces proliferation of smooth muscle cells via an endothelial cell-derived soluble factor (s). Infect Immun 67, 2909-2915 (1999)) (Pubitemid 29244707)
21. K L Godzik, E R O'Brien, S Wang, C Kuo: In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae. J Clin Microbiol 33, 2411-2414 (1995))
22. X Yang, D Coriolan, K Schultz, D T Golenbock, D Beasley: Toll-like receptor 2 mediates persistent chemokine release by Chlamydia pneumoniae-infected vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 25, 2308-2314 (2005)) (Pubitemid 41552647)
23. C A Gaydos, J T Summersgill, N N Sahney, J A Ramirez, T C Quinn: Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun 64, 1614-1620 (1996)) (Pubitemid 26129824)
24. T Kitazawa, A Fukushima, S Okugawa, S Yanagimoto, K Tsukada, K Tatsuno, K Koike, S Kimura, T Kishimoto, Y Shibasaki, Y Ota: Chlamydophilal antigens induce foam cell formation via c-Jun NH2-terminal kinase. Microbes Infect 9, 1410-1414 (2007)) (Pubitemid 350016974)
25. F Cao, A Castrillo, P Tontonoz, F Re, G I Byrne: Chlamydia pneumoniae-induced macrophage foam cell formation is mediated by Toll-like receptor 2. Infect Immun 75, 753-759 (2007)) (Pubitemid 46203437)
26. C L Mei, P He, B Cheng, W Liu, Y F Wang, J J Wan: Chlamydia pneumoniae induces macrophagederived foam cell formation via PPAR alpha and PPAR gamma-dependent pathways. Cell Biol Int 33, 301-8 (2009))
27. M Hogdahl, G Soderlund, E Kihlstrom: Expression of chemokines and adhesion molecules in human coronary artery endothelial cells infected with Chlamydia (Chlamydophila) pneumoniae. Apmis 116, 1082-1088 (2008))
28. A Kol, T Bourcier, A Lichtman, P Libby: Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. J Clin Invest 103, 571-577 (1999)) (Pubitemid 29094058)
29. J T Baer, T V du Laney, P B Wyrick, A S McCain, T A Fischer, E P Merricks, A S Baldwin, T C Nichols: Nuclear factor-kappaB activation in endothelium by Chlamydia pneumoniae without active infection. J Infect Dis 188, 1094-1097 (2003)) (Pubitemid 37338971)
30. R Ross: Atherosclerosis is an inflammatory disease. Am Heart J 138, S419-420 (1999)) (Pubitemid 29523224)
31. G K Hansson, P Libby: The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6, 508-519 (2006)) (Pubitemid 43980523)
32. E L'Her, P Sebert: A global approach to energy metabolism in an experimental model of sepsis. Am J Respir Crit Care Med 164, 1444-1447 (2001)) (Pubitemid 33124024)
33. J Koury, E A Deitch, H Homma, B Abungu, P Gangurde, M R Condon, Q Lu, D Z Xu, R Feinman: Persistent HIF-1alpha activation in gut ischemia/reperfusion injury: potential role of bacteria and lipopolysaccharide. Shock 22, 270-277 (2004)) (Pubitemid 39468993)
34. X Zheng, J L Ruas, R R Cao, F A Salomons, Y Cao, L Poellinger, T Pereira: Cell-type-specific regulation of degradation of hypoxia-inducible factor 1 alpha: role of subcellular compartmentalization. Mol Cell Biol 26, 4628-41 (2006)) (Pubitemid 43877580)
35. A Vink, A H Schoneveld, D Lamers, A J Houben, P van der Groep, P J van Diest, G Pasterkamp: HIF-1alpha expression is associated with an atheromatous inflammatory plaque phenotype and upregulated in activated macrophages. Atherosclerosis 195, 69-75 (2007))
36. P T Schumacker: Hypoxia-inducible factor-1 (HIF-1). Crit Care Med 33, S423-5 (2005)) (Pubitemid 41785978)
37. C Peyssonnaux, V Datta, T Cramer, A Doedens, E A Theodorakis, R L Gallo, N Hurtado-Ziola, V Nizet, R S Johnson: HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J Clin Invest 115, 1806-15 (2005)) (Pubitemid 40979719)
38. J Rupp, J Gieffers, M Klinger, G van Zandbergen, R Wrase, M Maass, W Solbach, J Deiwick, T Hellwig-Burgel: Chlamydia pneumoniae directly interferes with HIF-1alpha stabilization in human host cells. Cell Microbiol 9, 2181-2191 (2007)) (Pubitemid 47250290)
39. M Wimmer, R Sandmann-Strupp, P Saikku, R L Haberl: Association of chlamydial infection with cerebrovascular disease. Stroke 27, 2207-2210 (1996)) (Pubitemid 26427194)
40. P J Cook, D Honeybourne, G Lip, D G Beevers, R Wise, P Davies: Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham Stroke Project. Stroke 29, 404-410 (1998)) (Pubitemid 28086683)
41. M Elkind, I F Lin, J T Grayston, R L Sacco: Chlamydia pneumoniae and the risk of first ischemic stroke: The Northern Manhattan Stroke Study. Stroke 31, 1521-1525 (2000)) (Pubitemid 30437497)
42. B Fagerberg, J Gnarpe, H Gnarpe, S Agewall, J Wikstrand: Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: a prospective study in middle-aged to elderly men with treated hypertension. Stroke 30, 299-305 (1999)) (Pubitemid 29071793)
43. A Vink, M Poppen, A H Schoneveld, P Roholl, D de Kleijn, C Borst, G Pasterkamp: Distribution of Chlamydia pneumoniae in the human arterial system and its relation to the local amount of atherosclerosis within the individual. Circulation 103, 1613-1617 (2001)) (Pubitemid 32246606)
44. J Wohlschlaeger, M Wimmer, D K Nagler, R Haberl, S Weis: Identification of Chlamydia pneumoniae in intracranial and extracranial arteries in patients with stroke and in controls: combined immunohistochemical and polymerase chain reaction analyses. Hum Pathol 36, 395-402 (2005)) (Pubitemid 40591810)
45. M Voorend, A J van der Ven, B Kubat, J Lodder, C A Bruggeman: Limited Role for C. pneumoniae, CMV and HSV-1 in Cerebral Large and Small Vessel Atherosclerosis. Open Neurol J 2, 39-44 (2008))
46. R Virmani, F D Kolodgie, A P Burke, A Farb, S M Schwartz: Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 20, 1262-1275 (2000)) (Pubitemid 30262927)
47. M Slevin, A B Elasbali, M M Turu, J Krupinski, L Badimon, J Gaffney: Identification of differential protein expression associated with development of unstable human carotid plaques. Am J Pathol 168, 1004-1021 (2006)) (Pubitemid 43327751)
48. Z G Nadareishvili, D E Koziol, B Szekely, C Ruetzler, R LaBiche, R McCarron, T J DeGraba, S Jander: Increased CD8 (+) T cells associated with Chlamydia pneumoniae in symptomatic carotid plaque. Stroke 32, 1966-1972 (2001)) (Pubitemid 32868080)
49. A Ciervo, F Mancini, P Sale, A Russo, A Cassone: Real-time polymerase chain reaction and laser capture microdissection: an efficient combination tool for Chlamydophila pneumoniae DNA quantification and localization of infection in atherosclerotic lesions. Int J Immunopathol Pharmacol 21, 421-8 (2008)) (Pubitemid 351988407)
50. A Meijer, P J Roholl, S K Gielis-Proper, J M Ossewaarde: Chlamydia pneumoniae antigens, rather than viable bacteria, persist in atherosclerotic lesions. J Clin Pathol 53, 911-916 (2000))
51. M Kaplan, S S Yavuz, B Cinar, V Koksal, M S Kut, F Yapici, H Gercekoglu, M M Demirtas: Detection of Chlamydia pneumoniae and Helicobacter pylori in atherosclerotic plaques of carotid artery by polymerase chain reaction. Int J Infect Dis 10, 116-23 (2006)) (Pubitemid 43255598)
52. S Carr, A Farb, W H Pearce, R Virmani, J S T Yao: Atherosclerotic plaque rupture in symptomatic carotid artery stenosis. J Vasc Surg 23, 755-765; discussion 765-756 (1996))
53. R Sessa, M Di Pietro, G Schiavoni, A Petrucca, P Cipriani, C Zagaglia, M Nicoletti, I Santino, M del Piano: Measurement of Chlamydia pneumoniae bacterial load in peripheral blood mononuclear cells may be helpful to assess the state of chlamydial infection in patients with carotid atherosclerotic disease. Atherosclerosis 195, e224-30 (2007)) (Pubitemid 47561974)
54. T Cramer, Y Yamanishi, B E Clausen, I Förster, R Pawlinski, N Mackman, V H Haase, R Jaenisch, M Corr, V Nizet, G S Firestein, H P Gerber, N Ferrara, R S Johnson: HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112, 645-57 (2003)) (Pubitemid 36331777)
55. S P Didion: Chlamydophila pneumoniae and endothelial activation: the smoke that precedes the fire of atherosclerosis? Circ Res 102, 861-863 (2008)) (Pubitemid 351591539)
56. C C Kuo, L A Jackson, L A Campbell, J T Grayston: Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 8, 451-461 (1995))
57. M B Aldous, J T Grayston, S P Wang, H M Foy: Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979. J Infect Dis 166, 646-649 (1992))
58. D Virok, Z Kis, L Karai, L Intzedy, K Burian, A Szabo, B Ivanyi, E Gonczol: Chlamydia pneumoniae in atherosclerotic middle cerebral artery. Stroke 32, 1973-1976 (2001)) (Pubitemid 32868082)